Moreover, Read et al. reported that PTTG1 and PBF (PTTG1IP, PTTG1 interacting protein) together modulate the interaction with TP53, reduce p53 protein stability and affect its downstream targets which lead to worse outcomes in HNSCC patients [34]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.